| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030810 Nucleotide and amino acid sequence of voltage-gated transport protein; for diagnosis and therapy of nervous system disorders; antiepileptic agents |
| 02/29/2000 | US6030808 Nucleic acids encoding receptor recognition factor stat 3 and methods of use thereof |
| 02/29/2000 | US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents |
| 02/29/2000 | US6030798 Method of identifying a lipase for treatment of digestive disorders |
| 02/29/2000 | US6030797 Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof |
| 02/29/2000 | US6030796 Complementary dna sequence which codes for a chimeric antibody directed to an extracellular epitope of the human trans-plasma membrane p-glycoprotein to strongly suppress drug efflux and increase cytotoxicity of anticancer agents |
| 02/29/2000 | US6030795 Recombinant TGF-β type I receptor variants having differentially diminished capacity to signal for matrix protein production |
| 02/29/2000 | US6030791 For diagnosis, prevention and treatment of disease states or conditions associated with excessive tissue wasting |
| 02/29/2000 | US6030790 Kit for detecting active human parathyroid hormone including two sets of antibodies or antibody fragments; for diagnosis |
| 02/29/2000 | US6030786 Antisense modulation of RhoC expression |
| 02/29/2000 | US6030638 Plasmid for in vivo expression of prostaglandin synthase |
| 02/29/2000 | US6030635 Malleable paste for filling bone defects |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030618 Therapeutic and prophylactic methods using heat shock proteins |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030613 Receptor specific transepithelial transport of therapeutics |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | US6030609 Method and composition for treating paramyxovirus |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2149940C Patch-type device for transdermal delivery of insulin |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/29/2000 | CA1340915C Myeloperoxydase humaine et application therapeutique |
| 02/28/2000 | CA2281055A1 Antithrombin iii-beta-comprising pharmaceutical preparation |
| 02/24/2000 | WO2000009735A1 A cyclic lipopeptide from cryptosporiopsis quercina possessing antifungal activity |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009713A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009694A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009692A1 Novel peptides capable of modulating inflammatory heart disease |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009688A1 Novel gene and protein osbh encoded thereby |
| 02/24/2000 | WO2000009687A1 Novel gene and protein gmp30 encoded thereby |
| 02/24/2000 | WO2000009684A1 NUCLEIC ACID CAPABLE OF BINDING SPECIFICALLY TO Ras TARGET PROTEIN |
| 02/24/2000 | WO2000009678A1 Irak3 polypeptides, polynucleotides and methods |
| 02/24/2000 | WO2000009676A2 Methods of forming neurons |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009673A1 Dnazymes and methods for treating hpv-related disorders |
| 02/24/2000 | WO2000009667A1 Calcineurin-dependent control of skeletal muscle fiber type |
| 02/24/2000 | WO2000009666A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009657A2 Methods of modulating of angiogenesis |
| 02/24/2000 | WO2000009653A2 Method of inhibiting cathepsin k |
| 02/24/2000 | WO2000009562A1 Novel cleaved fragments of fibrinogen |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009557A1 Novel gene and protein pgth encoded thereby |
| 02/24/2000 | WO2000009556A1 Human lysophospholipase gene (cbfblh05) |
| 02/24/2000 | WO2000009553A2 Antimicrobial peptides isolated from the skin of american frogs |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009546A1 Process for the preparation of regular glycopeptides |
| 02/24/2000 | WO2000009545A1 Pentapeptide lhrh analogs |
| 02/24/2000 | WO2000009544A1 Heptapeptide lhrh analogs |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009540A1 Purification of blood clotting proteins |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | WO2000009532A1 Methods and compositions for modulating transcription by use of antibodies to transcription factors |
| 02/24/2000 | WO2000009526A2 Method for dpc4 (smad4) nuclear localization |
| 02/24/2000 | WO2000009525A2 Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009165A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 02/24/2000 | WO2000009160A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | WO2000009155A1 Methods and compositions for preventing anti-gal production in xenograft recipients |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
| 02/24/2000 | WO2000009153A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | WO2000009152A1 Therapeutic chemokine receptor antagonists |
| 02/24/2000 | WO2000009151A1 Regulation of dendritic cell trafficking |
| 02/24/2000 | WO2000009150A2 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| 02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
| 02/24/2000 | WO2000009148A1 Vascular endothelial growth factor 3 |
| 02/24/2000 | WO2000009147A1 Blood sugar level controlling agent |
| 02/24/2000 | WO2000009146A1 Treatment of disease states |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009144A1 Methods to increase blood flow to ischemic tissue |
| 02/24/2000 | WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | WO2000009142A1 Methods for treatment of neurological disorders |
| 02/24/2000 | WO2000009138A1 Nutritional compositions for preventing or treating hyperlipoproteinemia |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009120A1 New use of taxoid derivatives |
| 02/24/2000 | WO2000009113A1 Use of zeranol to modulate reproductive cycles |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009093A1 Microemulsions as solid dosage forms for oral administration |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000009085A2 Oral formulation containing cyclosporin |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | WO2000009018A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | WO2000002905A3 Methods for accelerating bone and cartilage growth and repair |
| 02/24/2000 | WO2000002579A3 Component b as angiogenic agent in combination with human growth factors |
| 02/24/2000 | WO2000001820A3 Nucleic acid molecules encoding nuclear hormone receptor coactivators, and uses thereof |